Skip to content

Should seniors get the BOOSTRIX vaccine? A comprehensive guide

4 min read

The Centers for Disease Control and Prevention (CDC) reports a single dose of the Tdap vaccine, like BOOSTRIX, is a cost-effective intervention for adults aged 65 and older. So, should seniors get the BOOSTRIX vaccine? This guide will break down the essential information for older adults considering this important booster.

Quick Summary

Current CDC guidance recommends that older adults who have not received a Tdap vaccine get a single dose, and BOOSTRIX is specifically approved for this age group. It provides protection against tetanus, diphtheria, and pertussis (whooping cough), which can be severe in the elderly.

Key Points

  • CDC recommends BOOSTRIX: The CDC advises older adults who have never had a Tdap shot to get a single dose.

  • BOOSTRIX is FDA-approved for seniors: Unlike the Adacel Tdap vaccine, BOOSTRIX is specifically approved by the FDA for individuals aged 65 and older.

  • Protects against pertussis: The vaccine is crucial for preventing whooping cough, which can be severe in older adults and can be spread to vulnerable infants.

  • Mild, manageable side effects: Common side effects are usually mild and include pain, redness, or swelling at the injection site.

  • Good safety profile in elderly: Studies confirm BOOSTRIX has a safety profile comparable to the standard Td vaccine in older adults.

  • Provides protection for the community: Getting vaccinated helps protect people who are at higher risk of serious disease, such as newborns.

  • Necessary for wound management: For deep wounds, a tetanus booster is required if the last one was more than 5 years ago, and Tdap is preferred.

In This Article

The Importance of the Tdap Vaccine for Older Adults

Vaccines are not just for children; they are a critical part of maintaining health throughout the lifespan. While many seniors received childhood vaccinations, the immunity from these can wane over time. The Tdap vaccine boosts protection against three dangerous diseases: tetanus, diphtheria, and pertussis.

  • Tetanus: Caused by bacteria found in soil, it can enter the body through wounds and lead to severe muscle spasms known as 'lockjaw'.
  • Diphtheria: This serious bacterial infection can cause breathing problems, heart failure, and nerve damage.
  • Pertussis (Whooping Cough): This highly contagious respiratory illness causes severe coughing fits and can lead to serious complications like pneumonia and even death, especially in infants and older adults.

For seniors, who may have weakened immune systems, whooping cough can be particularly dangerous. Furthermore, many outbreaks of pertussis are traced back to adults who unknowingly transmit the disease to vulnerable infants who are too young to be vaccinated. By getting the BOOSTRIX vaccine, seniors not only protect themselves but also help create a "cocoon" of safety for those around them, including their grandchildren.

BOOSTRIX vs. Adacel and Standard Td Vaccine

Seniors have two main options for Tdap vaccines: BOOSTRIX and Adacel. There is also the standard Td vaccine, which covers only tetanus and diphtheria. The key differences in their recommendations for seniors are worth noting.

Feature BOOSTRIX (Tdap) Adacel (Tdap) Td (Tetanus & Diphtheria)
FDA Approval for Seniors (65+)? Yes No; only approved for people aged 10-64 Yes
Protects Against Pertussis? Yes Yes (though not approved for seniors) No
CDC Recommendation for 65+? Preferred for people 65+ when feasible Can be used if BOOSTRIX is unavailable; valid protection Can be used for 10-year booster after initial Tdap dose
First Tdap for Senior? Recommended for a single dose if they've never had a Tdap before. Valid if administered, but BOOSTRIX is preferred. Not recommended for the initial Tdap dose, as it lacks pertussis protection.
Subsequent 10-year Boosters? Acceptable for the every-10-year booster. Not approved for people 65+. Acceptable for the every-10-year booster.

Note: The CDC advises that providers should not miss an opportunity to vaccinate seniors with Tdap, and that either available Tdap vaccine can be considered valid, even if BOOSTRIX is the preferred option for the 65+ age group.

Boostrix Efficacy and Safety in Seniors

Since its approval for use in older adults in 2011, the effectiveness and safety of BOOSTRIX have been studied. Studies based on initial antibody levels in seniors demonstrate its immunogenicity, confirming it provides protection against tetanus, diphtheria, and pertussis.

Research has also confirmed the vaccine's safety profile in seniors is comparable to the standard Td vaccine. In fact, a Kaiser Permanente study found that adverse events in seniors following Tdap vaccination were mostly minor, and the overall risk was comparable to the Td vaccine. These findings should reassure both clinicians and older adults about the safety of receiving a Tdap booster.

Common side effects in seniors are typically mild and localized, such as pain, redness, or swelling at the injection site. Fatigue, headache, and gastrointestinal symptoms are also possible but less frequent. Serious side effects are rare.

Contraindications and Considerations for the BOOSTRIX Vaccine

While BOOSTRIX is safe for most people, certain conditions may prevent or delay vaccination. It is important to discuss your full medical history with your healthcare provider before getting the vaccine.

Key contraindications include:

  • A known history of a severe allergic reaction (anaphylaxis) to any component of BOOSTRIX or to a previous dose of any tetanus, diphtheria, or pertussis vaccine.
  • A history of encephalopathy (brain disease) that occurred within 7 days of a previous pertussis-containing vaccine and was not caused by something else.

Reasons for deferring vaccination include:

  • Progressive or unstable neurological conditions: This can include things like active strokes. Your provider will evaluate if it's safe to proceed.
  • Guillain-Barré syndrome (GBS): If you developed GBS within 6 weeks of receiving a prior tetanus-toxoid-containing vaccine, the risks and benefits must be carefully considered.
  • Arthus-type hypersensitivity reaction: For those who experienced this severe local reaction to a previous tetanus-containing vaccine, it's recommended to wait at least 10 years before getting another tetanus booster.
  • Immunosuppression: For individuals with weakened immune systems due to conditions or therapies, the vaccine may be less effective.

Conclusion

For seniors who have never received a Tdap vaccine, a single dose of BOOSTRIX is a strongly recommended and safe way to protect against tetanus, diphtheria, and whooping cough. The vaccine not only safeguards the individual from potentially serious complications of these diseases but also helps prevent the spread of pertussis to vulnerable populations, such as infants. While minor and temporary side effects are possible, serious reactions are rare. By consulting with a healthcare provider and being aware of any potential contraindications, seniors can confidently take this important step for their health and the health of their community.

Frequently Asked Questions

No, while BOOSTRIX is the only Tdap vaccine specifically approved by the FDA for individuals 65 and older, the CDC states that providers should not miss an opportunity to vaccinate seniors with any Tdap vaccine they have available. Either can provide a valid dose of protection.

For adults, including seniors, the CDC recommends getting a Tdap booster shot once if they have never received one. After this initial Tdap dose, a booster of either Tdap or Td is recommended every 10 years to maintain protection.

The most common side effects are generally mild and localized to the injection site, including pain, redness, and swelling. Less common side effects can include headache, fatigue, and gastrointestinal symptoms.

Serious side effects from the BOOSTRIX vaccine are rare. Studies on the vaccine's safety in seniors found its side-effect profile is comparable to the standard Td vaccine, and most reactions are minor.

In adults, whooping cough symptoms can sometimes be mistaken for a persistent cough, but it can lead to serious complications like pneumonia. More importantly, unvaccinated adults are a common source of infection for infants, who are most vulnerable to severe, life-threatening cases.

If an individual is immunosuppressed, including those receiving immunosuppressive therapy, the immune response to the vaccine may not be as robust as expected. The decision to vaccinate should be made in consultation with a healthcare provider.

If a senior has a deep or serious wound and has not had a tetanus-toxoid-containing vaccine in the last five years, a Tdap booster is recommended. In this situation, Tdap is preferred over the Td vaccine for wound management, especially if they have not had a Tdap previously.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.